Condition
Respiratory Syncytial Virus Infections clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Respiratory Syncytial Virus Infections clinical trials that are recruiting, at sites in 11 countries (most in United States (3), China (3), Vietnam (2)). By phase: Phase 1/2 (3), Phase 3 (2), Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 11Countries
Newest Respiratory Syncytial Virus Infections clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ziresovir (AK0529) for high-risk adults with RSV infection | Phase 2/3 | Beijing, Beijing Municipality and 8 other locations | Recruiting | Jun 22, 2026 |
| Recombinant RSV Vaccine (CHO Cell) with Adjuvant in Adults 18+ in China | Phase 1/2 | Zigong, Sichuan | Recruiting | May 13, 2026 |
| RSV strains and illness burden in Vietnamese adults aged 60 and older | — | Ho Chi Minh City, Southern Vietnam | Recruiting | Nov 20, 2025 |
| S-337395 for high-risk adults with symptomatic RSV | Phase 2 | Los Angeles, California and 88 other locations | Recruiting | Oct 9, 2025 |
| Evaluating a new treatment to prevent severe COVID-19 complications | Phase 1/2 | Alcalá de Henares, Madrid and 2 other locations | Recruiting | Nov 12, 2024 |
| Inhaled interferon α1b treatment for RSV in young children | Phase 3 | Beijing, Beijing Municipality | Recruiting | Apr 12, 2024 |
| Identifying biomarkers linked to severity in adults with RSV infections | — | Créteil | Recruiting | Jan 9, 2024 |
| Testing a new RSV vaccine in infants and children | Phase 1/2 | La Mesa, California and 17 other locations | Recruiting | Dec 19, 2022 |
| Azithromycin treatment for children with severe RSV respiratory failure | Phase 3 | Birmingham, Alabama and 14 other locations | Recruiting | Aug 30, 2021 |
All recruiting trials (9)
-
Ziresovir (AK0529) for high-risk adults with RSV infection
This study tests whether Ziresovir can shorten RSV-related lower respiratory tract illness in high-risk adults compared with placebo.
-
Recombinant RSV Vaccine (CHO Cell) with Adjuvant in Adults 18+ in China
This is a two-part study testing a recombinant RSV vaccine in adults to see if it is safe and whether it provokes an immune response, with older adults (60+) included in the second part.
-
RSV strains and illness burden in Vietnamese adults aged 60 and older
This project will test how common RSV is and which strains and severity patterns occur in people aged 60+ who are hospitalized with acute respiratory illness or worsening heart/lung disease.
-
S-337395 for high-risk adults with symptomatic RSV
This trial will test whether taking the antiviral S-337395 within 72 hours of symptoms helps nonhospitalized adults with RSV who are at high risk of progressing to severe illness.
-
Evaluating a new treatment to prevent severe COVID-19 complications
This study is testing a new treatment to see if it can help hospitalized COVID-19 patients avoid severe complications caused by inflammation.
-
Inhaled interferon α1b treatment for RSV in young children
This study is testing a new inhaled treatment for RSV in young children under 2 years old to see if it helps them get better and is safe to use.
-
Identifying biomarkers linked to severity in adults with RSV infections
This study is trying to find specific markers in the body that can help doctors understand how severe Respiratory Syncytial Virus (RSV) infections are in adults who are hospitalized.
-
Testing a new RSV vaccine in infants and children
This study is testing a new RSV vaccine in infants and young children to see if it is safe and effective in boosting their immune response against the virus.
-
Azithromycin treatment for children with severe RSV respiratory failure
This study is testing if the antibiotic Azithromycin can help children with severe respiratory failure caused by RSV feel better and recover faster.
Related topics
Quick answers
How many Respiratory Syncytial Virus Infections clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (3 trials), China (3 trials), Vietnam (2 trials), Spain (1 trial), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 3: 2, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.